2Malfertheiner P. Helicobacter pylori: screen and treat[J]. Dtsch Med Wochenschr, 2014,139(17) : 905-908.
3Ma B, Hang L, Chen G,et al. Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting[J]. West Indian Med J,2013,62(2) : 135-139.
4Jung J,Bae KH,Jeong CS. Anti-Helicobacter pylori and antiulcerogenic activities of the root cortex of Paeonia suf- fruticosa[J]. Biol Pharm Bull, 2013,36(10) : 1535-1539.
5Kurosaki Y,Kawashima M,Teramoto S. Two cases of pul- monary myeobacterium avium complex disease with resis- tance to clarithromycin[J]. Kekkaku, 2014,89 (5) : 565-569.
6Mikamo H,Yamagishi Y,Matsubara S. Infection and host reaction[J]. Jpn J Antibiot, 2013,66 (6) : 305-310.
7Perut F,Avnet S,Fotia C,et al. V-ATPase as an effective therapeutic target for sarcomas[J]. Exp Cell Res, 2014,320 (1):21-32.
8Akdogan RA,Ozgur O,Gueuyeter S,et al. A pilot study of Helicobacter pylori genotypes and eytokine gene polymor- phisms in reflux oesophagitis and peptic ulcer disease[J]. Bratisl Lek Listy, 2014,115(4) : 221-228.
9Prevete N,Rossi FW,Rivellese F,et al. Helieobaeter py- lori HP(2-20) induces eosinophil activation and accumu- lation in superficial gastric mucosa and stimulates VEGF- alpha and TGF-beta release by interacting with formyl- peptide receptors[J]. Int J Immunopathol Pharmacol,2013, 26(3 ) : 647-662.
10Abdo-Franeis JM. Peptic ulcer,NSAID and Helieobaeter[J]. Rev Gastroenterol Mex, 2013,78 (Suppl 1 ) : 8-9.
